Tom Oakley was appointed chief operating officer at Inotiv in February 2019 and is currently responsible for leading its operations across five sites. An executive with over 25 years of leadership, strategy, and operations experience, he joined Inotiv as part of the 2018 acquisition of Seventh Wave Laboratories, where he served as CEO. Prior to his tenure there, Oakley led DTO Associates management consultants and served as president and chief operating officer at MPI Research, president and CEO of ChanTest Corporation, and president and CEO of Bridge Laboratories. He has also held leadership positions with the Sarah Cannon Research Institute and Covance.
Oakley served in the U.S. Army and was honorably discharged with the rank of captain. He holds an MBA in management, finance and accounting from the Kellogg School of Management at Northwestern University.